Treating urine infections is becoming increasingly challenging due to rising antibiotic resistance. Here's what's driving ...

Urinary tract infections (UTIs) are among the most common bacterial infections, affecting millions worldwide. However, the increasing resistance of bacteria to standard antibiotics has made ...

The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections in nearly ... by bacteria including E. coli, Klebsiella pneumoniae, Citrobacter ...

GSK plc GSK announced that the FDA has approved its oral antibiotic gepotidacin for treating uncomplicated urinary tract infections ... like Escherichia coli, Klebsiella pneumoniae, Citrobacter ...

The antibiotic, branded as Blujepa, is approved for women aged 12 years and older to treat uncomplicated UTIs, which are bacterial infections affecting the lower urinary tract in otherwise healthy ...

The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections in nearly three decades ... UTIs caused by bacteria including E. coli, Klebsiella ...

Blujepa, a first-in-class oral antibiotic, is approved for treatment of uUTIs caused by Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus, and ...

GSK said the U.S. Food and Drug Administration approved its Blujepa oral antibiotic ... be used against urinary tract infections caused by the microorganisms Escherichia coli, Klebsiella ...

TUESDAY, March 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult ...

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of oral antibiotics ... coli, Klebsiella pneumoniae, Citrobacter freundii ...

Researchers from Lund University discovered that Klebsiella pneumoniae bacteria found in Ukraine war-wounded victims are not only resistant to all antibiotics but are also particularly aggressive ...